Effectiveness of the switch from insulin to incretin therapy in patients with long-lasting type 2 diabetes: a 6-month longitudinal, real-life study

被引：0
|
作者：
Citarrella, R. [1 ]
Di Vittorio, M. [1 ]
Bonfiglio, A. [1 ]
Speciale, S. [1 ]
Ruggirello, D. [1 ]
Castellino, G. [1 ]
Chianetta, R. [1 ]
Nikolic, D. [1 ]
Mannina, C. [1 ]
Montalto, G. [1 ]
机构：
[1] Univ Palermo, DIBIMIS, Palermo, Italy
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
744
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [1] Comparison of insulin lispro and regular insulin in a 6-month Japanese study in patients with type 1 or type 2 diabetes
    Brunelle, RL
    Oda, E
    Terashima, Y
    Ito, Y
    Andersdon, JH
    DIABETES, 2002, 51 : A466 - A466
  • [2] Real-life prescription patterns of insulin for patients with type 2 diabetes in The Netherlands
    Heintjes, E. M.
    Plat, A. W.
    Thomsen, T. Lyager
    Christensen, T. E.
    Beest, F. J. A. Penning-van
    Herings, R. M. C.
    DIABETOLOGIA, 2009, 52 : S356 - S356
  • [3] Real-life glycemic control in patients with type 2 diabetes treated with insulin therapy: A prospective, longitudinal cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 9])
    Fujita, Naotaka
    Yamamoto, Yosuke
    Hayashino, Yasuaki
    Kuwata, Hirohito
    Okamura, Shintaro
    Iburi, Tadao
    Furuya, Miyuki
    Kitatani, Masako
    Yamazaki, Shin
    Ishii, Hitoshi
    Tsujii, Satoru
    Inagaki, Nobuya
    Fukuhara, Shunichi
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 294 - 302
  • [4] Real-Life Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany
    Dworak, Markus
    Gruenberger, Jean-Bernard
    Bader, Giovanni
    DIABETES, 2013, 62 : A285 - A285
  • [5] Insulin Pump Therapy with Simple Scheme in Insufficiently Controlled Patients with Type 2 Diabetes on Intensive Injection Therapy-A Real-Life Study
    De Valk, Harold W.
    DIABETES, 2018, 67
  • [6] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Benucci, Maurizio
    Li Gobbi, Francesca
    Bandinelli, Francesca
    Damiani, Arianna
    Infantino, Maria
    Grossi, Valentina
    Manfredi, Mariangela
    Parisi, Simone
    Fusaro, Enrico
    Batticciotto, Alberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Meacci, Francesca
    IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 419 - 422
  • [7] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Maurizio Benucci
    Francesca Li Gobbi
    Francesca Bandinelli
    Arianna Damiani
    Maria Infantino
    Valentina Grossi
    Mariangela Manfredi
    Simone Parisi
    Enrico Fusaro
    Alberto Batticciotto
    Piercarlo Sarzi-Puttini
    Fabiola Atzeni
    Francesca Meacci
    Immunologic Research, 2017, 65 : 419 - 422
  • [8] Real-life study of patients treated with omalizumab for chronic spontaneous urticaria in France: 6-month data of the LUCIOL study
    Barbaud, A.
    Staumont-Salle, D.
    Bouillet, L.
    Vicaut, E.
    Tetart, F.
    Azib-Meftah, S.
    Milpied, B.
    Fougerousse, A.
    Karine, B.
    Pelvet, B.
    Le Guen, S.
    Berard, F.
    ALLERGY, 2019, 74 : 115 - 116
  • [9] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
    Schoettle, Daniel
    Janetzky, Wolfgang
    Luedecke, Daniel
    Beck, Elmar
    Correll, Christoph U.
    Wiedemann, Klaus
    BMC PSYCHIATRY, 2018, 18
  • [10] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
    Daniel Schöttle
    Wolfgang Janetzky
    Daniel Luedecke
    Elmar Beck
    Christoph U. Correll
    Klaus Wiedemann
    BMC Psychiatry, 18
12345